N=206 CRYO (n=76)
Age (years) 63 ± 11
Gender (% female) 20%
Hypertension (%) 21%
Diabetes (%) 10.5%
Ischaemic HD (%) 37%
Average CHADS2VASC score 2.66 ± 1.40
Average follow-up (months) 28.1 ± 12.9
Continuous monitoring (%) 34%
PPM (%) 1.3%
ICD (%) 14%
BiV (%) 17%
Implanted loop recorder 1.3%
Pre ablation LVEF 34 ± 8.7%
DCM (%) 47%
Ischaemic CM (%) 37%
Valvular (%) 5.2%
Hypertrophic (%) 0%
Other CM (%) 17%
LA diameter 46 ± 6.5
Paroxysmal AF (%) 29%
Persistent AF (%) (Including long standing persistent)
71%
Long-standing persistent AF (%) 26%
Average NYHA Class 2.37 ± 0.72
Medications Medications
Beta-blocker (%) 78%
ACE Inhibitor or ARB (%) 91%
Spirinolactone (%) 10%
AAD therapy (%) 54%
AAD therapy + Beta blocker (%) 89%
Amiodarone (%) 41%
Sotalol (%) 7.9%
Flecanide (%) 3.9%
Vitamin K antagonist (%) 32%
NOAC (%) 68%